Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-90.49	79.83	839.28
Graham Fair Price	-33.74	5782.45	8726.31
PEG	103.03	0.10	0.05
Price/Book	11.50	3.37	3.03
Price/Cash Flow	-35.93	-9.51	14.85
Prices/Earnings	-60.34	-4.27	-2.66
Price/Sales	-13.19	0.65	0.74
Price/FCF	-35.93	-9.51	14.85
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	4.52	0.33	0.32
Operating Margin	57.24	-0.02	-0.06
ROA	43.31	< 0.005	-0.01
ROE	-0.28	-0.20	30.46
ROIC	-0.01	-0.01	-16.24
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.06	-95.25
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	0.63	0.56	-10.32
EPS QOQ	0.57	0.45	-21.03
FCF QOQ	1.20	-2.38	97.95
Revenue QOQ	< 0.005	0.02	124.01
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	75.93	75.59	-0.44
Days Sales Outstanding (DSO)	40.78	41.55	1.90
Inventory Turnover	1.19	1.19	0.45
Debt/Capitalization	0.90	0.92	1.98
Quick Ratio	0.33	0.32	-3.60
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3450.39	2741.72	-20.54
Cash	9133.72	7642.12	-16.33
Capex	-12.84	-311.93	-2329.50
Free Cash Flow	703.21	-972.49	38.29
Revenue	14043.76	14333.53	2.06
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.51	0.51	0.45
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	608.52	60.34	-90.08
Naive Interpretation	Member

06 - Financial Health · Bad

Rating